10 Industrials Stocks With Whale Alerts In Today's Session
JPMorgan Says These 2 Value Stocks Are Among Its 'Best Idea' Picks for 2025
Everbright: Maintains the "Buy" rating for ASCLETIS-B. ASC47 combined with semaglutide shows superior effects.
Everbright released a research report stating that ASCLETIS-B (01672) is actively laying out its strategies in the MASH and weight loss sectors, and its progress is among the best in the country. Considering the company's effective control over various expenses, the net income forecast for 2024-2025 has been adjusted to -0.261/-0.313 billion yuan (previously -0.284/-0.34 billion yuan), and a new net income forecast for 2026 is -0.322 billion yuan, maintaining a "Buy" rating. The company released experimental data on the weight loss and muscle gain treatment drug ASC47 combined with semaglutide in obese mice; this drug is a fat-targeting, once-a-month subcutaneous injection of a thyroid hormone receptor β agonist.
Why the 'Dogs of the Dow' Stocks Just Might Deliver in 2025
3M Company (MMM): Among the Biggest Dividend Cuts and Suspensions of 2024
TCL has released the small blue wing C7 fresh air Air Conditioner, aiming to improve the "sleep" for 0.3 billion people suffering from insomnia.
According to a report from Sina Technology on the evening of December 23, TCL recently announced the launch of the TCL Xiaolan Wing C7 fresh air Air Conditioner, focusing on user needs in sleeping scenarios for bedrooms and purification scenarios for living rooms, aiming to create the most suitable air solution that meets smart health standards for consumers. Research data shows that the number of people suffering from insomnia in China is increasing year by year, surpassing 0.3 billion by 2023. Among the four major factors affecting sleep are temperature, noise, air quality, and human airflow sensation. It is introduced that the TCL Xiaolan Wing C7 fresh air Air Conditioner is designed to improve sleep, committed to utilizing AI sleep fresh air technology to create a healthy atmosphere.
Up & Down Wall Street: It Was an Eye-Opening Week for Stocks. What Comes Next
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
After GE's Spinoff Success, What's Next for Honeywell, FedEx
Express News | 3M And US Conec Announce Licensing Agreement For 3M Expanded Beam Optical Interconnect Technology
25 U.S. 'Highest Conviction' Stocks – UBS
Barclays Maintains 3M(MMM.US) With Buy Rating, Maintains Target Price $165
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
3M's Initial Full-Year Outlook Seen 'Better Than Feared,' UBS Says
Dow's Drop: How Blue-chips Have Fared During Index's Peak Turned Worst-run in Decades
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Dow's 115-Point Rally Highlighted By Gains For Shares Of UnitedHealth, NVIDIA Corp.
Express News | Mullen Announces 100 Class 1 and Class 3 EV Shipments With Sales Totaling $5.5M Through Dec. 18, While Reducing Company Burn to $5.3M Monthly Compared to $16.8M in August 2024
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today